Advances in Virology:
Xenotropic and Other Murine Leukemia Virus-Related Viruses in Humans
Call for Papers
XMRV is a new human retrovirus that was originally reported in patients with prostate cancer and chronic fatigue syndrome. Subsequent reports of failure/success to detect XMRV in similar patient populations by others have resulted in the current intense controversy related to the possible association of XMRV and these human diseases. Additionally, there are potential public health implications regarding XMRV transmission by blood transfusion. Moreover, murine retrovirus sequences related to polytropic murine leukemia viruses (MLVs) have recently been reported in some human samples.
The main focus of this special issue is presenting critical research toward development and standardization of sensitive assays for the detection of XMRV and related MLVs, understanding virus biology, and investigating virus transmission, with the important goals of investigating the risk of human infections and determining any disease associations. The special issue will be an international forum for researchers to present their most recent findings in the field, with special emphasis on results that can aid in resolving the clinical and public health concerns regarding XMRV and other MLV-related viruses in humans. The special issue will publish original research and review papers including, but are not limited to the following topics:
Murine leukemia viruses: background
Endogenous retroviruses: overview
Cross-species transmission of MLVs: a historical perspective
MLVs and host adaptations
Biology of murine retroviruses
XMRV: discovery and progress
XMRV: human infections
Gammaretroviruses: development of detection assays and standardization
XMRV and other related murine retroviruses in vitro studies
XMRV transmission: animal studies
Prevalence of MLVs in humans
Novel technologies for virus detection
Antiretroviral drugs and MLV infection
Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/av/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:
Manuscript Due March 1, 2011
First Round of Reviews June 1, 2011
Publication Date September 1, 2011
Lead Guest Editor
Arifa S. Khan, Laboratory of Retroviruses, Center for Biologics Research and Review, Food and Drug Administration, 8800 Rockville Pike, HFM-454, Building 29B, room 4NN10, Bethesda, ME, USA
Guest Editors
Myra McClure, Jefferiss Research Trust Laboratories, Wright-Fleming Institute, Faculty of Medicine, Imperial College London, St. Mary's Campus, Norfolk Place, Norfolk W2 1PG, UK
Yoshinao Kubo, Department of AIDS Research, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
Paul Jolicoeur, Laboratory of Molecular Biology, Clinical Research Institute of Montreal, University of Montreal, 110, Pine Avenue West Montreal, QC, Canada H2W 1R7
See also: Professor Myra McClure a new addition to the Wessely School of Denial ? or Professor Myra McClure: Nothing on God's Earth could persuade me to do more research on CFS
No comments:
Post a Comment